Drug repurposing offers a practical and efficient approach to developing treatments for conditions like cancer. Traditional drug development for cancer is both time-consuming and costly, often taking up to 18 years and costing billions of dollars. Drug repurposing, on the other hand, speeds up the development process and lowers costs by reusing drugs already approved for other conditions. For example, the oral cholera vaccine, widely used for people traveling to counties where the prevalence of cholera infection is high. Studies have shown potential benefit of the cholera vaccine against several cancers, including breast, colon, prostate, bladder, ovarian, lung, liver, pancreatic, and brain.
The cholera vaccine may have antitumor effects, potentially making it a candidate for cancer treatment. These include:
- Inhibition of cell proliferation: Interrupts the cancer cell cycle, either by blocking growth factor signals or inducing apoptosis, a form of programmed cell death.
- Tumor regression: In rats with chemically-induced breast tumors, the cholera vaccine led to significant tumor shrinkage.
- cAMP activation: Increases levels of cyclic adenosine monophosphate (cAMP), a molecule that plays a key role in many cellular processes. Elevated cAMP levels seem to inhibit cancer cell growth and activate specific types of protein kinases, which are enzymes that modify other proteins to regulate their activity.
- Hormone sensitivity: Decreases estrogen-binding activity in cells, which could be especially important for hormone-sensitive cancers like some forms of breast cancer.
- P53 protein acetylation: Induces the acetylation of the P53 tumor-suppressor protein by increasing the expression of the P300 enzyme. Acetylated P53 can lead to apoptosis, providing another mechanism to kill cancer cells.
- Immunomodulatory effects: Promotes the maturation of dendritic cells. These cells present antigens to T cells, essentially teaching the immune system to recognize and fight cancer cells.
- Gut microbiota influence: In a mouse model, the cholera vaccine improved the microbial environment in the gut, leading to reduced inflammation and a shift in immune responses that could be protective against colon cancer.
- Downregulation of inflammatory markers: In the same mouse model, the cholera vaccine reduced levels of inflammation-promoting neutrophils and increased levels of anti-inflammatory regulatory T cells in the colon, which can be a helpful response against colon cancer.
These findings are preliminary, and more research is needed to confirm these effects and understand their implications fully. Various lifestyle and environmental factors could also impact these outcomes.
Comments: Vaxchora® is the cholera vaccine that has been approved by the U.S. Food and Drug Administration (FDA). It is an oral, live-attenuated vaccine that comes in a packet of lyophilized (freeze-dried) powder that is reconstituted in a buffer solution (provided with the vaccine) to create a liquid suspension. The reconstituted vaccine is then ingested. Food, water, and other oral medications should be avoided for 60 minutes before and after taking the vaccine.
References:
